Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1991-06-19
1993-03-30
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
051984687
ABSTRACT:
Treatment or prevention of memory loss with a medicament consisting of an n-6 essential fatty acid selected from GLA, DGLA, AA, adrenic acid and the 22:5 n-6 acid and an n-3 essential fatty acid selected from the 18:4 n-3 and 20:4 n-3 acids, EPA, the 22:5 n-3 acid and DHA.
REFERENCES:
patent: 4355027 (1982-10-01), Growdon et al.
patent: 4753964 (1988-06-01), Horrobin
patent: 4810497 (1989-03-01), Horrobin
patent: 4851431 (1989-07-01), Yehuda
The Merck Manual of Diagnosis and Therapy, 15th Ed. p. 1481, 1987.
Chem Abst., 106:195209n, 1987.
Chem Abst., 101:71570a, 1984.
Efamol Holdings PLC
Rollins John W.
LandOfFree
Essential fatty acid composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Essential fatty acid composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Essential fatty acid composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281318